Ed Sheeran was already facing one of the most frightening periods of his life when doctors discovered a tumor in his pregnant ...
Tumor treating fields have demonstrated efficacy and safety, especially in glioblastoma treatment, but clinical uptake ...
Kazia Therapeutics (KZIA) said Tuesday that data showed its paxalisib therapy significantly reduced tumor burden and the total amount of cancer in the body by 52% in a preclinical model of ...
Kazia Therapeutics (KZIA) said Tuesday that it will expand its ongoing paxalisib clinical trial into hormone receptor-positive, HER2-negative advanced breast cancer after preclinical data showed ...
Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a ...
Juniper Biosciences today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to JBS-003 (18F-fluoromisonidazole, or FMISO), the first-in-class ...
Women who used the Depo-Provera birth control shot and were later diagnosed with a meningioma brain tumor rarely follow the ...
An exploratory analysis from the SECOMBIT trial showed differences in outcomes based on thymidine kinase activity in ...
Biologic therapy may alter the gut microbiome in patients with autoimmune arthritis, with specific microbial patterns linked to treatment response.
Allogene Therapeutics stock is trying to create CAR-T treatments using cells from healthy donors. Here's what investors need ...
A type C meeting between IDEAYA Biosciences and the FDA has established the design of a phase 3 registrational trial for ...
Tevimbra plus Ziihera with chemo raises survival in first-line HER2-positive gastroesophageal cancer, offering a new FDA-approved option.